Healthcare provider profile · identity verified

Munawar Hayat, MD

Family Practice · FLOWER MOUND, TX · NPI 1285044487

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	342	105
Amlodipine Besylate	Amlodipine Besylate	276	83
Levothyroxine Sodium	Levothyroxine Sodium	259	75
Lisinopril	Lisinopril	199	65
Rosuvastatin Calcium	Rosuvastatin Calcium	194	58
Metoprolol Succinate	Metoprolol Succinate	168	54
Gabapentin	Gabapentin	154	58
Metformin Hcl	Metformin Hcl	147	49
Losartan Potassium	Losartan Potassium	121	42
Tamsulosin Hcl	Tamsulosin Hcl	116	41
Pantoprazole Sodium	Pantoprazole Sodium	115	42
Montelukast Sodium	Montelukast Sodium	111	36
Tramadol Hcl	Tramadol Hcl	101	36
Omeprazole	Omeprazole	96	31
Hydrochlorothiazide	Hydrochlorothiazide	85	26
Duloxetine Hcl	Duloxetine Hcl	82	23
Trazodone Hcl	Trazodone Hcl	78	26
Pravastatin Sodium	Pravastatin Sodium	77	24
Glimepiride	Glimepiride	75	23
Fluticasone Propionate	Fluticasone Propionate	74	48
Simvastatin	Simvastatin	74	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	72	24
Alprazolam	Alprazolam	71	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	71	21
Albuterol Sulfate Hfa	Albuterol Sulfate	69	33
Zolpidem Tartrate	Zolpidem Tartrate	68	25
Clonazepam	Clonazepam	61	14
Meloxicam	Meloxicam	60	26
Olmesartan Medoxomil	Olmesartan Medoxomil	58	18
Escitalopram Oxalate	Escitalopram Oxalate	56	17
Azithromycin	Azithromycin	54	49
Carvedilol	Carvedilol	54	20
Furosemide	Furosemide	53	22
Metformin Hcl Er	Metformin Hcl	51	20
Metoprolol Tartrate	Metoprolol Tartrate	51	16
Ondansetron Odt	Ondansetron	51	16
Synthroid	Levothyroxine Sodium	43	13
Ozempic	Semaglutide	41	12
Clopidogrel	Clopidogrel Bisulfate	40	14
Prednisone	Prednisone	40	29
Sertraline Hcl	Sertraline Hcl	40	16
Allopurinol	Allopurinol	38	12
Citalopram Hbr	Citalopram Hydrobromide	38	12
Celecoxib	Celecoxib	37	21
Pioglitazone Hcl	Pioglitazone Hcl	37	13
Valsartan	Valsartan	37	11
Clonidine Hcl	Clonidine Hcl	36	21
Azelastine Hcl	Azelastine Hcl	33	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	22
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Mounjaro	Tirzepatide	33	suppressed
Potassium Chloride	Potassium Chloride	33	13
Eliquis	Apixaban	32	13
Finasteride	Finasteride	31	suppressed
Bupropion Xl	Bupropion Hcl	30	suppressed
Lorazepam	Lorazepam	30	suppressed
Alendronate Sodium	Alendronate Sodium	29	suppressed
Trulicity	Dulaglutide	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	24
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	22
Propranolol Hcl	Propranolol Hcl	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Famotidine	Famotidine	27	14
Ezetimibe	Ezetimibe	26	suppressed
Atenolol	Atenolol	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	12
Liothyronine Sodium	Liothyronine Sodium	24	suppressed
Cefdinir	Cefdinir	23	23
Xarelto	Rivaroxaban	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Ketoconazole	Ketoconazole	21	14
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Jardiance	Empagliflozin	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Naproxen	Naproxen	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Methylprednisolone	Methylprednisolone	18	18
Telmisartan	Telmisartan	18	suppressed
Estradiol	Estradiol	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	12
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Glipizide	Glipizide	15	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	15	suppressed
Mupirocin	Mupirocin	15	11
Baclofen	Baclofen	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	12
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Etodolac	Etodolac	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Flecainide Acetate	Flecainide Acetate	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error